November 21, 2006
MILFORD, Mass.--Waters Corporation (NYSE: WAT - News) announced today it has entered into an agreement to acquire all the outstanding capital stock of ERA, a privately held company located in Arvada, Colorado, U.S.A., for an undisclosed amount. The transaction is expected to be complete before the end of 2006. Current annual revenues for ERA are [...]
November 17, 2006
New Demonstration Centers Highlight Agilent’s Full Portfolio of Life Sciences and Chemical Analysis Capabilities SANTA CLARA, Calif.--Agilent Technologies Inc. (NYSE:A) today launched a new product demonstration center at its Santa Clara, Calif., corporate headquarters, showcasing its life sciences and chemical analysis capabilities. The Center of Excellence launch follows Monday’s opening of a similar center in [...]
Ocimum Biosolutions acquires European based Oligo manufacturing company – Isogen Life Science
November 17, 2006
November 17, 2006, IJsselstein/Hyderabad - Ocimum Biosolutions, a leading provider of laboratory information management systems (LIMS), bioinformatics solutions, Microarrays and contract research headquartered in Hyderabad, India, has acquired the BioMolecules synthesis business of Isogen Life Science based in The Netherlands. Ms. Anuradha Acharya, CEO of Ocimum Biosolutions said “We are very pleased to have taken [...]
November 13, 2006
Woburn, MA, November 13, 2006 - Nova Analytics Corporation is pleased to announce the acquisition of Ebro Electronics GmbH & Co. KG (Ebro) from KPS Special Situation Funds (KPS). Headquartered in Ingolstadt, Germany, Ebro Electronic GmbH (www.ebro.com) is one of the leading producers of instruments that measure temperature, pressure, humidity, and pH. Its products include [...]
Illumina Signs Definitive Agreement to Acquire Solexa
November 13, 2006
SAN DIEGO & HAYWARD, Calif.--Illumina, Inc. (NASDAQ: ILMN - News) and Solexa, Inc. (NASDAQ: SLXA - News) announced today that they have entered into a definitive merger agreement under which Illumina will acquire Solexa in a stock-for-stock merger. Under the merger agreement, which was unanimously approved by the Boards of Directors of both companies, Solexa's [...]
Alcan to sell Wheaton Science Products Business
November 9, 2006
Montreal, Canada — Alcan has entered into an agreement to sell its Wheaton Science Products business in New Jersey, U.S.A. to River Associates Investments, LLC, a private equity group headquartered in Chattanooga, Tennessee. The parties expect to complete the transaction in November, following regulatory approval. “Alcan Global Pharmaceutical Packaging is focusing resources on its primary [...]
November 6, 2006
ORLANDO, Fla., November 6, 2006 -- Ometric Corporation announced today at the ISPE Annual Meeting the addition of wireless capabilities to its process control systems for the pharmaceutical industry. The upgrade, called SpectrInline Processware(TM) Pharma 2.0, will allow manufacturers to engage in real-time, in-line process control with remote access capabilities. SpectrInline Processware(TM) Pharma 2.0's compact [...]
VWR International, Inc. Opens a Wholly Owned Subsidiary in INDIA
October 31, 2006
WEST CHESTER, PA, October 31, 2006 - VWR International, Inc., a leader in the global research laboratory industry, announced today the establishment of a full-service, wholly owned subsidiary in Bangalore, INDIA to better serve the needs of the rapidly expanding pharmaceutical and biotech industry in the subcontinent. The new office for VWR Lab Products Private [...]
QIAGEN Acquires Genaco Biomedical Products, Inc.
October 30, 2006
VENLO, The Netherlands, October 30, 2006 - QIAGEN N.V. (Nasdaq: QGEN; Frankfurt, Prime Standard: QIA), a leading provider of molecular diagnostics products and the world’s premier supplier of solutions for preanalytical sample preparation, today announced that it acquired all outstanding shares of Genaco Biomedical Products, Inc. (Genaco). Genaco is an early-stage company applying a proprietary [...]
October 24, 2006
Lonza Group, the global life sciences company, today announces an agreement with Cambrex Corporation (NYSE: CBM) to purchase its Research Bioproducts business and its Microbial Biopharmaceutical business for a cash consideration of US$ 460 million. In conjunction with the planned Initial Public Offering of Polynt S.p.A., these acquisitions will accelerate the group’s strategic development and [...]
